首頁 > 市場調查報告書 > 醫療設備

導管

介入性心臟病器材市場規模、佔有率及成長分析（按產品、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898587

介入性心臟病器材市場規模、佔有率及成長分析（按產品、最終用戶及地區分類）－2026-2033年產業預測

Interventional Cardiology Devices Market Size, Share, and Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，介入性心臟病學設備市場規模將達到 148.6 億美元，到 2025 年將達到 159.5 億美元，到 2033 年將達到 280.2 億美元，預測期（2026-2033 年）的複合年成長率為 7.3%。

由於創新心血管技術的進步和監管流程的簡化，介入性心臟病器材市場正經歷顯著成長。介入性心臟科醫師專注於使用導管——一種用於微創手術（如血管成形術和支架置入術）的軟性管——為傳統手術提供有效的替代方案。這些器械主要用於治療由高血壓和糖尿病等疾病引起的心臟疾病，以及可能導致動脈斑塊積聚的周邊血管問題。現有器材包括導管、球囊、支架和濾器，體現了介入技術的多樣性。然而，嚴格的政府監管和核准流程給市場帶來了挑戰，並可能阻礙其擴張。總體而言，在技術進步和患者接受度提高的推動下，該領域預計將持續成長。

介入性心臟病器材市場促進因素

飽和脂肪酸攝取量增加、鹽攝取過量、飲酒和吸菸等不健康的生活習慣是導致冠狀動脈疾病風險上升的重要因素，預計這將推動介入性心臟病器材市場的成長。此外，吸煙率高且久坐的生活方式也進一步促進了市場擴張，因為缺乏體能活動與肥胖率上升和其他心血管疾病風險增加密切相關。這些因素共同凸顯了對能夠有效應對日益嚴重的冠狀動脈疾病負擔的先進介入性心臟病器械的迫切需求。

介入性心臟病器材市場限制因素

介入性心臟病器材市場面臨許多限制因素，包括不斷變化的客戶需求和複雜的醫療設備認證監管要求。由於涉及諸多法律問題，應對這些法規結構可能極具挑戰性。為確保醫療設備的性能和質量，需要進行全面的評估以保障公眾安全。因此，醫療設備嚴格的多方面認證標準可能會阻礙市場擴張和創新。這種複雜性為製造商設置了障礙，使其難以推出新產品和新技術，最終影響該行業的市場動態和成長潛力。

介入性心臟病器材市場趨勢

由於肥胖和不健康的生活方式導致心血管疾病盛行率不斷上升，介入性心臟病學器械市場正經歷顯著成長。吸菸、過量飲酒和缺乏運動等因素導致冠狀動脈疾病發生率不斷攀升，推動了對先進介入治療方案的需求。這些器械使心臟科醫生能夠進行微創手術，從而改善患者預後並減少併發症。對快速有效治療方案的關注正在推動器材技術的創新，隨著醫療保健系統優先考慮高效的心血管護理以應對日益嚴重的心臟疾病負擔，預計該市場將強勁擴張。

冠狀動脈支架
- 裸金屬支架（BMS）
- 藥物釋放型支架（DES）
- 其他
結構性心臟裝置
- 心臟瓣膜
- 閉合裝置及其他
血管成形球囊
導管
- 診斷導管
- 血管造影術
- IVUS
- 治療性導管
- 動脈粥狀硬化斑塊切除術
- 血栓切除術
- 消融
栓塞保護裝置

全球介入性心臟病器材市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

醫院及門診手術中心
導管檢查室及其他

全球介入性心臟病器材市場規模及複合年成長率（2026-2033）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corporation
Medtronic PLC
Terumo Corporation
Biotronik SE & Co. KG
Biosensors International Group Ltd
ACIST Medical Systems
Cardinal Health, Inc.
Cook Medical Inc.
Koninklijke Philips NV
Edwards Lifesciences Corporation
Nano Therapeutics Pvt. Ltd.
AngioDynamics, Inc.
Inari Medical, Inc.
Genetesis, Inc.
OptiMed Medical Instruments GmbH
Meril Life Sciences Pvt. Ltd.
OrbusNeich Medical

結論與建議

簡介目錄

Product Code: SQMIG35A2171

Interventional Cardiology Devices Market size was valued at USD 14.86 Billion in 2024 and is poised to grow from USD 15.95 Billion in 2025 to USD 28.02 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The interventional cardiology devices market is experiencing significant growth, driven by advancements in innovative cardiovascular technologies and streamlined regulatory processes. Interventional cardiologists specialize in using catheters-flexible tubes essential for minimally invasive procedures like angioplasty and stenting, offering viable alternatives to traditional surgeries. These devices primarily address heart ailments caused by conditions such as hypertension and diabetes while also catering to peripheral vascular issues that can lead to arterial plaque buildup. Available devices include catheters, balloons, stents, and filters, underscoring the versatility of interventional techniques. However, the market faces challenges from stringent government regulations and approval processes, which could potentially hinder its expansion. Overall, the sector is poised for growth, bolstered by technological advancements and increasing patient acceptance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Interventional Cardiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Interventional Cardiology Devices Market Segments Analysis

Global Interventional Cardiology Devices Market is segmented by product, end user and region. Based on product, the market is segmented intocoronary stents, structural heart devices, angioplasty balloons, catheters and embolic protection devices. Based on end user, the market is segmented into hospitals & ASCS and catheterization labs & others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Interventional Cardiology Devices Market

The rising prevalence of unhealthy lifestyle habits, such as the consumption of saturated fats, excessive salt, alcohol use, and smoking, is significantly contributing to an elevated risk of coronary artery disease, which, in turn, is expected to drive growth in the interventional cardiology devices market. Additionally, high rates of tobacco use and a sedentary lifestyle are further propelling market expansion, as physical inactivity is linked to increased obesity rates and further cardiovascular health issues. The combination of these factors underscores the urgent need for advanced interventional cardiology devices that can address the growing burden of coronary artery disease effectively.

Restraints in the Interventional Cardiology Devices Market

The Interventional Cardiology Devices market faces significant constraints due to evolving customer demands coupled with intricate regulatory requirements for medical device approval. Navigating these regulatory frameworks can be challenging due to the various legal considerations involved. Ensuring the performance and quality of medical devices necessitates thorough evaluation to protect public safety. Consequently, the rigorous and multifaceted certification standards imposed on medical devices may hinder the market's expansion and innovation. These complexities create barriers for manufacturers, making it difficult to introduce new products and advancements, ultimately impacting market dynamics and growth potential in the sector.

Market Trends of the Interventional Cardiology Devices Market

The Interventional Cardiology Devices market is witnessing significant growth, propelled by the rising prevalence of cardiovascular diseases linked to obesity and unhealthy lifestyle choices. As coronary artery disease cases escalate due to factors such as smoking, excessive alcohol consumption, and sedentary habits, there is an increasing demand for advanced interventional solutions. These devices enable cardiologists to conduct minimally invasive procedures, enhancing patient outcomes and reducing complications. The focus on rapid and effective treatment options is driving innovation in device technology, positioning the market for robust expansion as healthcare systems prioritize efficient cardiovascular care to address the rising burden of heart-related ailments.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis
Trade Analysis
Raw Material Analysis

Global Interventional Cardiology Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Coronary Stents
- Bare-Metal Stent (Bms)
- Drug-Eluting Stent (Des)
- Others
Structural Heart Devices
- Heart Valves
- Occluders & Others
Angioplasty Balloons
Catheters
- Diagnostic Catheters
- Angiography
- Ivus
- Treatment Catheters
- Atherectomy
- Thrombectomy
- Ablation
Embolic Protection Devices

Global Interventional Cardiology Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Ascs
Catheterization Labs & Others

Global Interventional Cardiology Devices Market Size & CAGR (2026-2033)

North America (Product, End User)
- USA
- Canada
Europe (Product, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACIST Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Therapeutics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetesis, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptiMed Medical Instruments GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OrbusNeich Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments